查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1736702

全球整形外科植入市场规模（按植入类型、应用、终端用户、区域范围和预测）

Global Orthopedic Implants Market Size By Kind Of Implant, By Application, By Final User (Hospitals, Ambulatory Surgical Centers Orthopedic Clinics), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

整形外科植入市场规模及预测

2024 年整形外科植入市场规模价值为 495.1 亿美元，预计到 2032 年将达到 700.9 亿美元，2026 年至 2032 年的复合年增长率为 4.90%。

整形外科植入是用于修復或支撑骨折和关节的医疗设备。螺丝、钢板、棒和人工关节用于辅助癒合过程并恢復功能。整形外科植入常用于关节置换、骨折矫正和脊椎固定等手术。

它们的应用范围广泛，包括创伤、退化性疾病和先天性疾病，确保不同患者群体成功治疗。材料科学和生物技术的进步预示着整形外科植入前景光明。

3D列印植入和适应生理变化的智慧材料等创新治疗方法有望改善治疗效果，为更个人化的医疗和更好的患者照护铺平道路。

全球整形外科植入市场动态

影响全球整形外科植入市场的关键市场动态是：

关键市场驱动因素

骨关节炎和肌肉骨骼疾病盛行率不断上升：全球范围内，骨关节炎和其他肌肉骨骼疾病的发生率正在上升，这主要是由于人口老化和肥胖率上升。这一趋势增加了对整形外科手术的需求，尤其是髋关节和膝关节手术等关节关节重建手术。随着医疗保健系统响应这项需求，整形外科植入製造商正在优先考虑创造性解决方案，以改善患者的治疗效果。例如，世界卫生组织 (WHO) 在 2023 年 3 月报告称，关节相关疾病的发生率急剧上升，这促使整形外科医疗保健支出增加。

植入设计和材料的技术进步：整形外科植入技术的创新，例如微创手术技术和先进生物材料的开发，正在显着推动市场成长。近期的进展使得植入具有更好的生物相容性、更快的恢復时间和更高的整体性能。 2023年1月，史赛克公司推出了一系列采用增强材质设计的全新整形外科植入，以提高强度和耐用性，彰显了市场对技术进步的关注。

政府措施与投资：近期政府为改善医疗基础设施而推出的措施正在推动整形外科植入业务的发展。例如，美国卫生与公众服务部于2023年6月宣布了一项500万美元的计划，用于支持整形外科技术研究并促进创新。这项资金旨在促进创新并改善治疗方案，从而鼓励更多公司投资整形外科领域。

运动医学需求日益增长：随着越来越多的人参与运动和健身，运动相关伤害的数量也在增加，这推动了对整形外科植入的需求。各公司正在开发专门用于治疗运动伤害的植入和器械，从而推动该领域的市场成长。施乐辉公司于2023年8月宣布将扩大其运动医学产品系列，彰显其对这一快速成长领域的投入。

主要问题

植入和手术费用高昂：整形外科植入和手术费用昂贵，限制了病患（尤其是在较贫穷的国家）的就医机会。这种经济障碍可能会阻碍市场扩张，因为医疗保健系统和患者可能会寻求替代疗法，甚至完全放弃重要的治疗方案。

严格的监管要求：整形外科植入市场受到严格监管，以确保病患安全和产品有效性。满足这些严格的标准对公司而言可能既耗时又昂贵，这可能导致产品发布延迟，并产生高昂的开发成本，进而影响盈利。

来自替代疗法的竞争：整形外科植入产业面临物理疗法、药物疗法和生物疗法等非侵入性疗法的竞争。随着患者寻求侵入性较小的治疗方案来缓解疼痛和改善行动能力，对外科植入的需求可能会下降，迫使製造商调整策略。

併发症和植入失败：患者可能会因为感染疾病、植入失败、不良反应等风险而避免接受整形外科手术。这些风险要求植入设计和材料不断进步，这增加了製造商的开发负担，同时也影响了患者的信心和对整形外科治疗的接受度。

主要趋势

植入和手术费用高昂：整形外科植入和手术治疗费用昂贵，限制了患者获得治疗的机会，尤其是在较贫穷的国家。此类经济障碍可能会阻碍市场扩张，因为医疗保健系统和患者可能会寻求替代药物，甚至完全放弃重要的治疗。

严格的监管要求：整形外科植入市场受到严格监管，以确保病患安全和产品有效性。满足这些严格的标准对公司而言可能既耗时又昂贵，这可能导致产品发布延迟，并产生高昂的开发成本，进而影响盈利。

来自替代疗法的竞争：整形外科植入产业面临物理疗法、药物疗法和生物疗法等非侵入性疗法的竞争。随着患者寻求侵入性较小的治疗方案来缓解疼痛和改善行动能力，对外科植入的需求可能会下降，迫使製造商调整策略。

併发症和植入失败：患者可能会因为感染疾病、植入失败、不良反应等风险而避免接受整形外科手术。这些风险要求植入设计和材料不断进步，这增加了製造商的开发负担，同时影响了患者的信心和对整形外科治疗的采用。

目录

第一章全球整形外科植入市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球整形外科植入市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球整形外科植入市场（植入类型）

  • 概述
  • 短人工关节
  • 脊椎移植

第六章全球整形外科植入市场（按应用）

  • 概述
  • 髋关节植入
  • 膝关节植入
  • 脊椎移植
  • 肩关节关节移植

第七章全球整形外科植入市场（按终端用户）

  • 概述
  • 医院
  • 门诊手术中心（ASC）
  • 整形外科诊所

第八章全球整形外科植入市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东

第九章全球整形外科植入市场竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第十章 公司简介

  • Johnson & Johnson Services Inc.
  • Zimmer Biomet
  • Stryker Corporation
  • Medtronic plc
  • Smith & Nephew plc
  • Exactech, Inc.
  • B. Braun Melsungen AG.

第十一章 附录

  • 相关调查
简介目录
Product Code: 40163

Orthopedic Implants Market Size And Forecast

Orthopedic Implants Market size was valued at USD 49.51 Billion in 2024 and is projected to reach USD 70.09 Billion by 2032, growing at a CAGR of 4.90% from 2026 to 2032.

Orthopedic implants are medical devices that repair or support broken bones and joints. Screws, plates, rods, and prosthetic joints are used to aid in the healing process and restore function. Orthopedic implants are commonly used in surgeries to replace joints, correct fractures, and stabilize the spine.

Their applications cover a wide range of ailments, including trauma, degenerative diseases, and congenital problems, ensuring successful therapy for a diverse patient population. Advancements in materials science and biotechnology point to a hopeful future for orthopedic implants.

Innovations like 3D-printed implants and smart materials that adapt to physiological changes are expected to improve treatment outcomes, paving the path for more personalized medicine and better patient care.

Global Orthopedic Implants Market Dynamics

The key market dynamics that are shaping the global orthopedic implants market include:

Key Market Drivers:

Increasing Prevalence of Osteoarthritis and Musculoskeletal Disorders: The frequency of osteoarthritis and other musculoskeletal problems is increasing worldwide, owing mostly to an ageing population and rising obesity rates. This tendency drives up demand for orthopedic procedures, notably joint replacements such as hip and knee surgery. As healthcare systems respond to this need, orthopedic implant makers prioritize creative solutions to improve patient outcomes. For example, in March 2023, the World Health Organization reported a surge in joint-related disorders, driving additional expenditure in orthopedic healthcare.

Technological Advancements in Implant Design and Materials: Innovations in orthopedic implant technology, including the development of minimally invasive surgical techniques and advanced biomaterials, are significantly driving market growth. Recent advancements have led to implants that offer better biocompatibility, reduced recovery times, and improved overall performance. In January 2023, Stryker Corporation launched a new range of orthopedic implants designed with enhanced materials that provide greater strength and durability, showcasing the market's focus on technological progress.

Governmental Initiatives and Investments: Recent government initiatives to improve healthcare infrastructure have boosted the orthopedic implants business. For example, in June 2023, the United States Department of Health and Human Services announced a $5 million project to support orthopedic technology research, thereby fostering innovation. This funding aims to foster innovation and improve treatment options, encouraging more companies to invest in the orthopedic sector.

Rising Need For Sports Medicine: As more people participate in sports and fitness activities, the number of sports-related injuries rises, driving up demand for orthopedic implants. Companies are reacting by creating specific implants and gadgets for treating sports injuries, hence boosting market growth in this area. Smith & Nephew announced the expansion of its sports medicine product portfolio in August 2023, demonstrating its commitment to serving this burgeoning sector.

Key Challenges:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Key Trends:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Global Orthopedic Implants Market Regional Analysis

Here is a more detailed regional analysis of the global orthopedic implants market:

North America:

North America dominates the orthopedic implants market, owing to improved healthcare infrastructure, large healthcare expenditures, and an aging population. The region's well-established medical device industry, combined with large investments in R&D, allows for the speedy introduction of breakthrough devices. Furthermore, the frequency of musculoskeletal problems, particularly among the elderly, drives up demand for orthopedic treatments such joint replacements. Medtronic announced a $50 million investment in August 2023 to enhance its orthopedic product offerings, demonstrating its commitment to meeting the demands of this increasing patient population.

Furthermore, supportive government initiatives and regulatory frameworks improve the market environment in North America. The United States Food and Drug Administration (FDA) has shortened approval processes for orthopedic implants, allowing new technologies to enter the market more quickly. In July 2023, the FDA announced a new initiative to expedite the clearance of innovative orthopedic devices, which is projected to drive further growth in this industry. As a result, the combination of technological breakthroughs, strong healthcare systems, and supportive regulatory frameworks places North America as a market leader for orthopedic implants.

Asia Pacific:

The Asia Pacific area is emerging as the fastest-growing market for orthopedic implants, owing to rising industrialization, urbanization, and increased healthcare investments. The burgeoning middle-class population in nations such as China and India is driving up disposable incomes, increasing demand for modern healthcare services such as orthopedic procedures. Furthermore, the rising frequency of osteoarthritis and sports-related injuries is increasing the demand for orthopedic implants. In May 2023, the Indian government proposed a $3 billion investment in healthcare infrastructure, which is likely to increase access to orthopedic care and, as a result, demand for implants.

Furthermore, the Asia Pacific market is seeing substantial improvements in manufacturing technologies, including as 3D printing and novel materials, which are increasing the availability and customisation of orthopedic implants. Companies are increasingly turning to local manufacturing to cut costs and increase supply chain efficiency. Stryker Corporation, for example, will open a new factory in Singapore in September 2023 to manufacture sophisticated orthopedic implants specifically for the regional market. This relocation underscores not only rising demand, but also the strategic importance of the Asia Pacific area in the worldwide orthopedic implants landscape.

Global Orthopedic Implants Market: Segmentation Analysis

The Global Orthopedic Implants Market is segmented on the basis of By Kind Of Implants, By Application, By Final User and By Geography.

Orthopedic Implants Market, By Kind of Implants

  • Short Joint Replacements
  • Spinal Implants

Based on Kind Of Implants, the Global Orthopedic Implants Market is segmented into Short Joint Replacements, Spinal Implants. The short joint replacements segment is the dominant category in the global orthopedic implants market, primarily due to the high prevalence of conditions like osteoarthritis and the increasing number of joint replacement surgeries. This segment benefits from advancements in implant technology and materials, leading to improved patient outcomes and higher adoption rates among healthcare providers. The spinal implants segment is the fastest growing segment in the orthopedic implants market, driven by the rising incidence of spinal disorders and an aging population.

Orthopedic Implants Market, By Application

  • Hip Implants
  • Knee Implants
  • Spine implants
  • Shoulder Implants

Based on Application, the Global Orthopedic Implants Market is segmented into Hip Implants, Knee Implants, Spine implants, Shoulder Implants. The knee implants segment is the dominant category in the global orthopedic implants market, largely due to the high incidence of knee-related conditions such as osteoarthritis. The increasing number of knee replacement surgeries, supported by advancements in implant technology and materials, drives substantial market demand. The spine implants segment is the fastest growing segment in the orthopedic implants market, fueled by the rising prevalence of spinal disorders and injuries. Innovations in spinal surgery techniques and the development of advanced spinal devices are enhancing treatment options and driving rapid growth in this area.

Orthopedic Implants Market, By Final User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Orthopedic Clinics

Based on Final User, the Global Orthopedic Implants Market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Orthopedic Clinics. The hospitals segment is the dominant category in the global orthopedic implants market, primarily due to the high volume of surgical procedures performed in these facilities. The ambulatory surgical centers (ASCs) segment is the fastest growing segment in the orthopedic implants market, driven by the increasing preference for outpatient procedures. ASCs offer cost-effective solutions, shorter recovery times, and improved patient convenience, leading to a rise in orthopedic surgeries performed in these settings.

Orthopedic Implants Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Orthopedic Implants Market are classified into North America, Europe, Asia Pacific, Rest of the World. North America is the dominant region, owing to its advanced industrial infrastructure and widespread use of precision measurement technologies across industries. The Asia Pacific region is the fastest growing, thanks to rapid industrialization, expanding manufacturing capabilities, and rising investments in technology and infrastructure in emerging economies such as China and India.

Key Players

The "Global Orthopedic Implants Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson Services Inc., Zimmer Biomet, Stryker Corporation, Medtronic plc, Smith & Nephew plc, Exactech, Inc. and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Orthopedic Implants Market Recent Developments
  • In July 2023, Zimmer Biomet introduced the Persona IQ knee implant, a smart orthopedic device with inbuilt sensors that provide real-time information about patient healing. This discovery marks a huge step forward in individualized orthopedic therapy, allowing for improved monitoring and customization of rehabilitation methods.
  • In August 2023, Medtronic has expanded its orthopedic product portfolio with the introduction of a new generation of sophisticated spinal implants intended to improve patient outcomes. These implants incorporate cutting-edge technology targeted at improving stability and reducing recovery times, demonstrating the company's dedication to meeting the demands of spine surgery patients.
  • In September 2023, Stryker launched a new manufacturing facility in Singapore to produce orthopedic implants, mainly knee and hip replacements. This facility intends to strengthen local supply chains and the availability of sophisticated orthopedic treatments in the Asia Pacific area, in response to rising demand for surgical implants.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ORTHOPEDIC IMPLANTS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL ORTHOPEDIC IMPLANTS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY KIND OF IMPLANTS

  • 5.1 Overview
  • 5.2 Short Joint Replacements
  • 5.3 Spinal Implants

6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hip Implants
  • 6.3 Knee Implants
  • 6.4 Spine implants
  • 6.5 Shoulder Implants

7 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY FINAL USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers (ASCs)
  • 7.4 Orthopedic Clinics

8 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East

9 GLOBAL ORTHOPEDIC IMPLANTS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Johnson & Johnson Services Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Zimmer Biomet
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Stryker Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Medtronic plc
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Smith & Nephew plc
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Exactech, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 B. Braun Melsungen AG.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments

11 Appendix

  • 11.1 Related Research